Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

Frequency and preventability of adverse drug events in the outpatient setting.

Wasserman RL, Edrees HH, Amato MG, et al. Frequency and preventability of adverse drug events in the outpatient setting. BMJ Qual Saf. 2024;Epub Jul 9. doi:10.1136/bmjqs-2024-017098.

Save
Print Download PDF
July 24, 2024
Wasserman RL, Edrees HH, Amato MG, et al. BMJ Qual Saf. 2024;Epub Jul 9.
View more articles from the same authors.

Adverse drug events (ADEs) remain a persistent patient safety challenge. This retrospective analysis of 3,323 patients treated in outpatient settings in 2018 found that 5% experienced an ADE. Most ADEs involved cardiovascular, central nervous system, or anti-infective medications. The researchers concluded that 22% of these ADEs were likely preventable through strategies such as improved education, training, communication, and monitoring or the use of clinical decision support tools or alerts.

Save
Print Download PDF
Cite
Citation

Wasserman RL, Edrees HH, Amato MG, et al. Frequency and preventability of adverse drug events in the outpatient setting. BMJ Qual Saf. 2024;Epub Jul 9. doi:10.1136/bmjqs-2024-017098.